TRANSCODE THERAPEUTICS RSS Feed | Nachrichten - www.finanzen.netwww.finanzen.net bietet Finanznachrichten zum weltweiten BörsengeschehenFinanzenhttps://www.finanzen.netde-definanzen.net GmbHFri, 22 May 2026 05:57:54 +0200https://images.finanzen.net/images/finanzen_net_neu.gifTRANSCODE THERAPEUTICS RSS Feed | Nachrichten - www.finanzen.nethttps://www.finanzen.netTransCode Therapeutics Announces Publication of Preclinical Data Supporting Therapeutic Potential of TTX-MC138 in GlioblastomaTue, 06 Jan 2026 14:01:00 +0100https://www.finanzen.net/nachricht/aktien/transcode-therapeutics-announces-publication-of-preclinical-data-supporting-therapeutic-potential-of-ttx-mc138-in-glioblastoma-15395234
  • TTX-MC138 is delivered to glioblastoma tumors in murine models of the disease, following intravenous injection
  • TTX-MC138 demonstrated suppression of miR-10b target and extended ...

    ]]>https://www.finanzen.net/nachricht/aktien/transcode-therapeutics-announces-publication-of-preclinical-data-supporting-therapeutic-potential-of-ttx-mc138-in-glioblastoma-15395234TransCode Therapeutics Expands Leadership with Appointment of Jack E. Stover to Board of DirectorsMon, 22 Dec 2025 14:01:00 +0100https://www.finanzen.net/nachricht/aktien/transcode-therapeutics-expands-leadership-with-appointment-of-jack-e-stover-to-board-of-directors-15374443

    BOSTON, Dec. 22, 2025 /PRNewswire/ -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), a clinical stage company ...

    ]]>    https://www.finanzen.net/nachricht/aktien/transcode-therapeutics-expands-leadership-with-appointment-of-jack-e-stover-to-board-of-directors-15374443    TransCode Therapeutics and Quantum Leap Healthcare Collaborative Launch a Phase 2a dose-expansion trial with TTX-MC138, following positive readouts from TransCode's Phase 1 trialThu, 11 Dec 2025 14:05:00 +0100https://www.finanzen.net/nachricht/aktien/transcode-therapeutics-and-quantum-leap-healthcare-collaborative-launch-a-phase-2a-dose-expansion-trial-with-ttx-mc138-following-positive-readouts-from-transcode-s-phase-1-trial-15352151

    BOSTON, Dec. 11, 2025 /PRNewswire/ -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ) and Quantum Leap Healthcare ...

    ]]>    https://www.finanzen.net/nachricht/aktien/transcode-therapeutics-and-quantum-leap-healthcare-collaborative-launch-a-phase-2a-dose-expansion-trial-with-ttx-mc138-following-positive-readouts-from-transcode-s-phase-1-trial-15352151